John Trachtenberg MD, FRCSC, FACS

Dr. John Trachtenberg is Professor of Surgery and Medical Imaging at the University of Toronto, where he held the Fleck Tanenbaum Chair in Prostatic Diseases at the University of Toronto and University Health Network. For over 25 years, Dr. Trachtenberg was a uro-oncologist at Toronto General Hospital and the Princess Margaret Cancer Centre where he was also Director of the Prostate Centre.

John received his BSc and MD from McGill University.

Marc B. Garnick, MD

Dr. Marc Garnick is a renowned expert in medical oncology and urologic cancer at Beth Israel Deaconess Medical Center in Boston and the Gorman Brothers Professor of Medicine at Harvard Medical School. He has dedicated his career to the development of new therapies for the treatment of prostate cancer, founding the Hershey Family Foundation for Prostate Cancer Research.

Marc is also a special adviser to the FDA and a member of the Penn Medicine Board.

Amy Lee Chong, MD, MBA, MSc

Medical Affairs – Global

Dr. Amy Lee Chong is a pediatrician and pediatric hematologist/oncologist with two decades of clinical experience in hospitals such as Our Ladies Children Hospital in Dublin and The Hospital for Sick Children (SickKids) in Toronto. As a former Canadian oncology portfolio medical director and global metastatic breast cancer medical lead for Eli Lilly, she has extensive industry, medical affairs, and commercialization expertise.

Amy also holds Master’s degrees from the University of Toronto (U of T) in Clinical Epidemiology and Healthcare Research, and from U of T’s Rotman School of Management in Business Administration in Healthcare and Life Sciences.

Craig Hawker, PhD

Polymers, US

Dr. Craig Hawker is the Co-Director of the California NanoSystems Institute and Director of the Dow Materials Institute at the University of California, Santa Barbara. He is a Distinguished Professor, holds the Alan and Ruth Heeger Chair in Interdisciplinary Science and is the Clarke Professor within the California Nanosystems Institute.

Craig is also an award-winning polymer scientist who holds 75 US patents and has co-authored over 600 papers in nanotechnology, materials science, and chemistry. He holds a BSc from the University of Queensland, and a PhD from the University of Cambridge.

Ikennah Browne, MD

Dr. Ikennah Browne is currently completing thoracic surgeon specialty training at St. Joseph’s Hospital in Hamilton, Ontario.

Dr. Browne earned his undergraduate degree in neuroscience at the University of Toronto, his medical degree from the University of Alberta and completed his surgical training at the University of Calgary and holds master’s degrees in Translational Medicine from UC San Francisco/UC Berkley and Health Administration from the University of British Columbia.

In 2018, Ikennah co-founded Voyage Biomedical, a medical device company aimed at revolutionizing the treatment of cardiac arrests that was acquired in 2021.

Trevor Reichman, MD, FRCSC

Dr. Reichman completed his residency in General Surgery at the University of Chicago Medical Center and subsequently performed a fellowship in Abdominal Organ Transplantation and HPB Surgery in Toronto between 2009 and 2011.

Following his fellowship, Dr. Reichman moved to the Ochsner Medical Center in New Orleans, Louisiana where he assumed the role of Co-Director of Living Donor Liver Transplantation and Pediatric Liver Transplantation. He also started and was the Director of the abdominal transplant fellowship at Ochsner.

After 5 years, he relocated to Virginia Commonwealth University in Richmond, Virginia where he was the Surgical Director of Liver Transplantation and the Director of Pediatric Liver Transplantation.

He is now returning to the Division of General Surgery and the UHN Transplant Program at TGH and is joining as a new member of the Abdominal Organ Transplant and HPB Surgery team. His research interests include Quality Improvement in Transplantation and racial disparities in outcomes from hepatocellular cancer.

He has assumed the role of Surgical Director of the Pancreas Transplant Program and is directing the surgical fellowships for abdominal transplantation and HPB surgery at the University of Toronto.

Karen Burke, PhD

Regulatory

Dr. Karen Burke was most recently Director of Regulatory Affairs, Drug Safety and Quality Assurance at Amgen Canada, and prior to that, Vice President, Regulatory Affairs at AstraZeneca Canada. She served as President of the 4,000-member Canadian Society for Chemistry during the International Year of Chemistry in 2010-2011. Dr. Burke was an active member of the research-based industry trade associations BIOTECanada and Rx&D (now Innovative Medicines Canada), and was a member of the Board of Directors of ethicscentre.ca, the Canadian Centre for Ethics & Corporate Policy.

Karen holds a PhD in organometallic chemistry from McMaster University.